Home New

Doing Muscular Dystrophy Treatment Since 1992

India’s Best Treatment Center for “Muscular Dystrophy”

IAMD Treating Muscular Dystrophy since 1992. IAMD has been transforming the lives of Muscular Dystrophy & other Neuromuscular disorders-affected families. In 2018, IAMD established the Integrated Muscular Dystrophy Rehabilitation Center (IMDRC), Solan, Himachal Pradesh; where patients can receive comprehensive Muscular Dystrophy Treatment care and management.

❝ The world of medical science has made a lot of progress with the help of research and innovation as well as state-of-the-art technology and equipment But some diseases, even today, remain a big challenge for us. The treatment and care of the patients with muscular dystrophy requires a great sense of service. Manav Mandir has become a new ray of hope for such patients.❞

Prime Minister Narendra Modi

(‘Mann Ki Baat’ address, 27 November 2022)

𝐕𝐢𝐫𝐞𝐧𝐝𝐞𝐫 𝐊𝐚𝐥𝐫𝐚

Virender Kalra, a soft-spoken warrior against Emery-Dreifuss Muscular Dystrophy, and a senior manager at Canara Bank Rajauri Garden Branch New Delhi, has left an enduring legacy. Despite losing his parents, he brought joy to every celebration.He has loving brothers and a motherly sister and whole lot of loving and caring nephews and nieces.
Dedicated to Canara Bank since 1995, he not only embodied liveliness but also steered the branch to be affectionately known as “Kalra Bank.” During a recent visit to the Integrated Muscular Dystrophy Rehabilitation Center in Solan, he proudly shared the impact of his contributions.

Beyond his banking career, Virender established the IAMD Rahat Physiotherapy Center in Delhi in 2014, located in his own residence. His boundless generosity made him a shining example of kindness and a true inspiration. Despite being wheelchair-bound since the age of 8, he led a dignified life, proving that dependence didn’t limit his independence. A philanthropist at heart, he transcended barriers, leaving an indelible mark on all who knew him.

Latest news & events

Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.
Obtaining a diagnosis

Do you have a diagnosis? You or your child has trouble walking or moving, but are unsure whether what is causing this? Read more to find out how you can obtain a diagnosis.

Managing Muscular Dystrophy at IMDRC Manav Mandir

IMDRC Manav Mandir has state of the art facilities to help you learn how to live successfully with Muscular Dystrophy. Learn about the types of therapies provided at IAMD.

About Muscular Dystrophy

Learn about Muscular Dystrophy, ongoing Muscular Dystrophy research and cures currently being explored.

How you can help us

IAMD needs your help to continue its mission. Here are some ways you can help us help those in need.

Seminer

Key supporters

IAMD Changing Lives Of People

Our Donors

Awards & Honourees